date:Jan 19, 2023
Multus Biotechnology has announced the close of a Series A funding round which has ended with the start-up receiving US$9.5 million. Multus, which produces ingredients for affordable cellular agriculture scaleup, will use the investment to build a UK-based production plant to produce growth media at commercial scale.
The investment will allow Multus to build a world-first production plant in the UK to accelerate the cultivated meat industry toward price parity with affordable food-safe growth